153 related articles for article (PubMed ID: 1659155)
21. Enhanced chemotaxis and superoxide anion production by polymorphonuclear leukocytes from nicotine-treated and smoke-exposed rats.
Gillespie MN; Owasoyo JO; Kojima S; Jay M
Toxicology; 1987 Jul; 45(1):45-52. PubMed ID: 3037731
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
Perez HD; Elfman F; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
[TBL] [Abstract][Full Text] [Related]
23. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of in vitro neutrophil responses to chemotactic factors by piroxicam.
Tanaka K; Kanaoka K; Egawa M; Abe N; Watanabe I; Hirai S
Jpn J Pharmacol; 1984 Jun; 35(2):181-91. PubMed ID: 6611436
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1.
Getting SJ; Flower RJ; Perretti M
Br J Pharmacol; 1997 Mar; 120(6):1075-82. PubMed ID: 9134220
[TBL] [Abstract][Full Text] [Related]
26. Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor. Distinct from the pathway for superoxide anion production.
Yasui K; Yamazaki M; Miyabayashi M; Tsuno T; Komiyama A
J Immunol; 1994 Jun; 152(12):5922-9. PubMed ID: 8207217
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil chemotaxis in rhesus macaques (Macaca mulatta).
Gonder JC; Thomas JM; Payne ES
Am J Vet Res; 1986 Apr; 47(4):860-2. PubMed ID: 3963588
[TBL] [Abstract][Full Text] [Related]
28. Modulation by interferons of human neutrophilic granulocyte migration.
Aas V; Lappegård KT; Siebke EM; Benestad HB
J Interferon Cytokine Res; 1996 Nov; 16(11):929-35. PubMed ID: 8938568
[TBL] [Abstract][Full Text] [Related]
29. Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis.
Harvath L; Balke JA; Christiansen NP; Russell AA; Skubitz KM
J Immunol; 1991 Feb; 146(3):949-57. PubMed ID: 1671052
[TBL] [Abstract][Full Text] [Related]
30. Chemotactic peptide-induced changes in neutrophil actin conformation.
Wallace PJ; Wersto RP; Packman CH; Lichtman MA
J Cell Biol; 1984 Sep; 99(3):1060-5. PubMed ID: 6470036
[TBL] [Abstract][Full Text] [Related]
31. Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP.
Azuma Y; Kosaka K; Kashimata M
Eur J Pharmacol; 2007 Jul; 568(1-3):260-8. PubMed ID: 17560994
[TBL] [Abstract][Full Text] [Related]
32. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.
Senior RM; Skogen WF; Griffin GL; Wilner GD
J Clin Invest; 1986 Mar; 77(3):1014-9. PubMed ID: 3005361
[TBL] [Abstract][Full Text] [Related]
33. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
Harvath L; Aksamit RR
J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
[TBL] [Abstract][Full Text] [Related]
34. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
Armstrong RA
Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of local anesthetics on migration, extracellular release of lysosomal enzyme, and superoxide anion production in human polymorphonuclear leukocytes.
Sasagawa S
Immunopharmacol Immunotoxicol; 1991; 13(4):607-22. PubMed ID: 1663527
[TBL] [Abstract][Full Text] [Related]
37. Concentration-dependent regulatory effects of prostaglandin E1 on human neutrophil function in vitro.
Farmer JC; Burkey TH; Kew RR; Webster RO
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):593-9. PubMed ID: 1654039
[TBL] [Abstract][Full Text] [Related]
38. N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism.
Kharazmi A; Nielsen H; Schiøtz PO
Int J Immunopharmacol; 1988; 10(1):39-46. PubMed ID: 3366508
[TBL] [Abstract][Full Text] [Related]
39. Increased Fc alpha R expression and IgA-mediated function on neutrophils induced by chemoattractants.
Hostoffer RW; Krukovets I; Berger M
J Immunol; 1993 May; 150(10):4532-40. PubMed ID: 8387096
[TBL] [Abstract][Full Text] [Related]
40. Methylxanthine bronchodilators potentiate multiple human neutrophil functions.
Schmeichel CJ; Thomas LL
J Immunol; 1987 Mar; 138(6):1896-903. PubMed ID: 2434564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
